PharmaCyte Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 126.60 K | $122.77 K | 0.00% | 1.86% |
| EQUITEC PROPRIETARY MARKETS, LLC | 11/26/2025 | 82.73 K | $80.21 K | 0.00% | 1.22% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 80.00 K | $77.57 K | 60.64% | 1.18% |
| VANGUARD GROUP INC | 11/07/2025 | 74.92 K | $72.67 K | -61.47% | 1.10% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 26.20 K | $25.40 K | 0.00% | 0.39% |
| NORTHERN TRUST CORP | 11/14/2025 | 19.21 K | $18.62 K | 0.00% | 0.28% |
| CITADEL ADVISORS LLC | 11/14/2025 | 14.53 K | $14.09 K | 100.00% | 0.21% |
| CITADEL ADVISORS LLC | 11/14/2025 | 10.60 K | $10.28 K | 100.00% | 0.16% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 5.55 K | $5.38 K | 99.32% | 0.08% |
| UBS GROUP AG | 11/13/2025 | 1.32 K | $1.28 K | -94.14% | 0.02% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 1.10 K | $1.00 K | 100.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 538 | $522 | -0.74% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 304 | $294 | -0.33% | 0.00% |
| ACCREDITED WEALTH MANAGEMENT, LLC | 11/12/2025 | 50 | $1 | 100.00% | 0.00% |
| SACHETTA, LLC | 10/24/2025 | 14 | $14 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 9 | $10 | 800.00% | 0.00% |
| BFSG, LLC | 10/29/2025 | 5 | $5 | 0.00% | 0.00% |
| FINANCIAL CONSULATE, INC | 10/21/2025 | 2 | $2 | 100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 2 | $2 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 1 | $1 | 100.00% | 0.00% |
| IFP ADVISORS, INC | 12/02/2025 | 1 | $1 | 0.00% | 0.00% |
| BLACKROCK, INC. | 11/12/2025 | 1 | $1 | 100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| KOESTEN, HIRSCHMANN & CRABTREE, INC. | 11/05/2025 | 0 | $0 | -100.00% | 0.00% |
| PARK SQUARE FINANCIAL GROUP, LLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PharmaCyte Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of PharmaCyte Biotech, Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 126,603
EQUITEC PROPRIETARY MARKETS, LLC: 82,727
RENAISSANCE TECHNOLOGIES LLC: 80,000
VANGUARD GROUP INC: 74,919
Schonfeld Strategic Advisors LLC: 26,200
NORTHERN TRUST CORP: 19,208
6.37% of PharmaCyte Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 538.64 K shares in the last 24 months. This purchase volume represents approximately $560.18 K in transactions.